<p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）於週五發佈了季度財報。該公司報告的每股收益（EPS）為（$0.05），低於市場共識預期的（$0.03），差距為（$0.02），據 Zacks 報道。該季度的收入為 1.65 億美元，而分析師預期為 1.6374 億美元。Cresco Labs 的股本回報率為負 11.77%，淨利潤率為負 6.67%。</p>
<h2>Cresco Labs 價格表現</h2>
<p>OTCMKTS:CRLBF 週五開盤價為$1.07。該股票的市值為 3.8085 億美元，市盈率為-7.13，貝塔係數為 1.51。Cresco Labs 的 1 年最低價為$0.43，1 年最高價為$1.62。該公司的 50 日簡單移動平均線為$1.21，200 日簡單移動平均線為$0.89。公司的流動比率為 3.10，速動比率為 2.22，債務與股本比率為 1.33。</p>
<h2>華爾街分析師觀點</h2>
<p>另外，Zacks Research 在 10 月 14 日（星期二）的一份研究報告中將 Cresco Labs 的股票評級從 “持有” 下調至 “強烈賣出”。一位研究分析師給予該股票 “強烈買入” 評級，一位給予 “持有” 評級，還有一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “持有”。</p>
<p><strong>獲取我們最新的 CRLBF 股票報告</strong></p>
<h2>關於 Cresco Labs</h2>
<p>（獲取免費報告）</p>
<p>Cresco Labs Inc 及其子公司在美國從事大麻產品的種植、製造和銷售。它提供以 Cresco 品牌銷售的花朵、大麻蒸汽筆、活樹脂、一次性筆和提取物；以 High Supply 品牌銷售的蒸汽罐、蒸汽筆、花朵、爆米花、搖晃、預卷、短卷和濃縮物；以 Good News 品牌銷售的蒸汽和軟糖；以 Wonder Wellness Co 品牌銷售的蒸汽和食品；以及以 Remedi 品牌銷售的酊劑、膠囊、藥膏和舌下油。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票超過 Cresco Labs</li>
<li>深入瞭解買賣差價</li>
<li>Rivian 的圖表顯示可以買入，但一些分析師仍然表示不建議買入</li>
<li>投資旅遊股票的好處</li>
<li>e.l.f.的拋售是買入的好時機，分析師表示</li>
<li>找到並盈利交易 52 周低點的股票</li>
<li>T-Mobile 是最被低估的巨型股票——現在是買入時機嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Cresco Labs 嗎？</h2>
<p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前買入……而 Cresco Labs 並不在名單上。</p>
<p>雖然 Cresco Labs 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得買入。</p>
<p>在這裏查看這五隻股票</p>

CRLBF

<p>Cresco Labs (OTCMKTS:CRLBF) 報告的季度每股收益為（$0.05），低於預期 $0.02。收入為 1.65 億美元，超過預期的 1.6374 億美元。該公司的股本回報率為負 11.77%，淨利潤率為負 6.67%。分析師已將該股票評級從 “持有” 下調至 “強烈賣出”，共識評級為 “持有”。該股票開盤價為 $1.07，市值為 3.8085 億美元，市盈率為 -7.13</p>

<p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. The business had revenue of $165.00 million during the quarter, compared to analyst estimates of $163.74 million. Cresco Labs had a negative return on equity of 11.77% and a negative net margin of 6.67%.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）於週五發佈了季度財報。該公司報告的每股收益（EPS）為（$0.05），低於市場共識預期的（$0.03），差距為（$0.02），據 Zacks 報道。該季度的收入為 1.65 億美元，而分析師預期為 1.6374 億美元。Cresco Labs 的股本回報率為負 11.77%，淨利潤率為負 6.67%。</p>
</div><h2>Cresco Labs Price Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 價格表現</h2>
</div><p>OTCMKTS:CRLBF opened at $1.07 on Friday. The stock has a market capitalization of $380.85 million, a PE ratio of -7.13 and a beta of 1.51. Cresco Labs has a 1-year low of $0.43 and a 1-year high of $1.62. The firm has a fifty day simple moving average of $1.21 and a 200 day simple moving average of $0.89. The company has a current ratio of 3.10, a quick ratio of 2.22 and a debt-to-equity ratio of 1.33.</p>
<div class="lb-trans"><p>OTCMKTS:CRLBF 週五開盤價為$1.07。該股票的市值為 3.8085 億美元，市盈率為-7.13，貝塔係數為 1.51。Cresco Labs 的 1 年最低價為$0.43，1 年最高價為$1.62。該公司的 50 日簡單移動平均線為$1.21，200 日簡單移動平均線為$0.89。公司的流動比率為 3.10，速動比率為 2.22，債務與股本比率為 1.33。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Separately, Zacks Research cut shares of Cresco Labs from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of &#34;Hold&#34;.</p>
<div class="lb-trans"><p>另外，Zacks Research 在 10 月 14 日（星期二）的一份研究報告中將 Cresco Labs 的股票評級從 “持有” 下調至 “強烈賣出”。一位研究分析師給予該股票 “強烈買入” 評級，一位給予 “持有” 評級，還有一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “持有”。</p>
</div><p><strong>Get Our Latest Stock Report on CRLBF</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 CRLBF 股票報告</strong></p>
</div><h2>About Cresco Labs</h2>
<div class="lb-trans"><h2>關於 Cresco Labs</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc 及其子公司在美國從事大麻產品的種植、製造和銷售。它提供以 Cresco 品牌銷售的花朵、大麻蒸汽筆、活樹脂、一次性筆和提取物；以 High Supply 品牌銷售的蒸汽罐、蒸汽筆、花朵、爆米花、搖晃、預卷、短卷和濃縮物；以 Good News 品牌銷售的蒸汽和軟糖；以 Wonder Wellness Co 品牌銷售的蒸汽和食品；以及以 Remedi 品牌銷售的酊劑、膠囊、藥膏和舌下油。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>A Deeper Look at Bid-Ask Spreads</li>
<li>Rivian’s Chart Says Go, But Some Analysts Still Say No</li>
<li>Investing in Travel Stocks Benefits</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Cresco Labs</li>
<li>深入瞭解買賣差價</li>
<li>Rivian 的圖表顯示可以買入，但一些分析師仍然表示不建議買入</li>
<li>投資旅遊股票的好處</li>
<li>e.l.f.的拋售是買入的好時機，分析師表示</li>
<li>找到並盈利交易 52 周低點的股票</li>
<li>T-Mobile 是最被低估的巨型股票——現在是買入時機嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Cresco Labs 嗎？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前買入……而 Cresco Labs 並不在名單上。</p>
</div><p>While Cresco Labs currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cresco Labs 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得買入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 公佈了財報，每股收益比預期低 $0.02